Hervana Overview
- Founded
- 2008
- Status
- Private
- Employees
- 3
- Latest Deal Type
- Grant
- Latest Deal Amount
- $997K
- Investors
- 1
Hervana General Information
Description
Developer of female non-hormonal contraceptives. The company develops a sperm motility-inhibiting probiotic agent which prevents fertilization and also protects against sexually transmitted diseases.
Contact Information
Primary Industry
Biotechnology
Primary Office
- Naftali 9/8
- Jerusalem
- Israel
+972 000-000-0000
Hervana Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 04-Jun-2012 | $997K | Completed | Startup | ||
| 2. Grant | 01-May-2010 | 00000 | Completed | Startup | ||
| 1. Angel (individual) | Completed | Startup |
Hervana Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Rachel Teitelbaum Ph.D | Founder & Co-Chief Executive Officer | ||
| David Zakai | Chief Operating Officer, Vice President, Business Development & Chief Business Officer |
Hervana Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHervana Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |